Wuhan Dazhong Dental Medical Co., Ltd.
2651.HK
Hong Kong Stock Exchange19.60
HKD
+0.25
- -
ISIN
CNE1000070K2
Return %
Stock
S&P500
1Y
-5.31
20.98
3Y
-5.31
70.79
5Y
-5.31
73.45
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Yao Xue
- Full Time Employees
- 1,065
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Address
- Huayin Building Wuhan HB People's Republic of China 430000
- IPO Date
- Jul 9, 2025
- Website
- chinadzyl.com
- Similar Companies
- Business
- Wuhan Dazhong Dental Medical Co., Ltd. operates as a comprehensive dental care provider focused on mass-market dentistry in Central China, underpinned by a network of dental out-patient departments, dental hospitals, and clinics. The company delivers a full spectrum of dental services and specialties, including general dentistry, implantology, and orthodontics, supported by a scalable clinical and operational platform designed to serve a high-volume patient base in tributary markets of Hubei and Hunan provinces. Headquartered in Wuhan, China, the company was founded in 2007 and operates as a subsidiary of Hubei Zhongshan Medical Investment Management Co., Ltd., reflecting its integration within a broader regional healthcare investment framework. Mandatory main products and services Wuhan Dazhong Dental Medical Co., Ltd. provides a comprehensive suite of dental care offerings organized into three primary product and service categories: general dentistry services (routine preventive care, diagnostics, restorative procedures, pedodontics, periodontics, endodontics, prophylaxis, and oral health management); implantology services (tooth replacement and rehabilitation using dental implants, planning, placement, and supported prosthetics); and orthodontics services (aesthetic and functional tooth alignment, including conventional and modern orthodontic treatments). These core offerings are supplemented by ancillary dental care activities such as paediatric dentistry, oral medicine, oral surgery, prosthodontics, and other chair-side treatments delivered across its network of facilities. The company emphasizes mass-market accessibility through a multi-site model, leveraging standardized clinical protocols, centralized procurement, and integrated patient management systems to optimize throughput and quality across its facilities. Latest major company changes The company undertakes ongoing expansion and optimization initiatives, including the opening of new dental out-patient departments and clinics to broaden market coverage in Central China; increases in dental chair capacity and patient flow through capital expenditure and efficiency measures; adoption of digital health and AI-assisted tools to augment diagnosis, treatment planning, and operational management; and continuous enhancements to its customer service platform and data-driven management practices. In recent reporting periods, the company discusses active diversification of its network to strengthen market position, scale its service capabilities, and advance cost-control measures through centralized management and process standardization. The organization has also pursued potential strategic alignment or collaborations within the broader healthcare investment ecosystem in Hubei and adjacent provinces to support its growth trajectory. Additional context Industry and segments: Medical care facilities; healthcare services with a focus on dental care. Business segments primarily include General Dentistry Services, Implantology Services, and Orthodontics Services, with potential ancillary services in paediatric dentistry, oral surgery, prosthodontics, and related specialties. Target markets and customers: mass-market dental patients in Central China, with emphasis on wide access for the general public and commercial dental care consumers. Geographic operations: operating primarily in Hubei and Hunan provinces, with headquarters in Wuhan, China. Founding year and headquarters: founded in 2007; headquartered in Wuhan, Hubei Province, China. Subsidiaries/parent relationships: an operating subsidiary of Hubei Zhongshan Medical Investment Management Co., Ltd., indicating a parent-subsidiary organizational structure within a regional medical investment framework.